These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23180494)

  • 21. The use, benefits, and costs of cholinesterase inhibitors for Alzheimer's dementia in long-term care: are the data relevant and available?
    Khang P; Weintraub N; Espinoza RT
    J Am Med Dir Assoc; 2004; 5(4):249-55. PubMed ID: 15228635
    [No Abstract]   [Full Text] [Related]  

  • 22. Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions: Evidence is not satisfactory.
    Landau R
    Dtsch Arztebl Int; 2011 Feb; 108(8):131; author reply 132. PubMed ID: 21403806
    [No Abstract]   [Full Text] [Related]  

  • 23. Donepezil use in managed Medicare: effect on health care costs and utilization.
    Fillit H; Gutterman EM; Lewis B
    Clin Ther; 1999 Dec; 21(12):2173-85. PubMed ID: 10645761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness analysis of donepezil for mild to moderate Alzheimer's disease in Taiwan.
    Fuh JL; Wang SJ
    Int J Geriatr Psychiatry; 2008 Jan; 23(1):73-8. PubMed ID: 17520661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Dementia with Lewy bodies. Clinical improvement under treatment with an acetylcholinesterase inhibitor].
    Omerovic M; Teipel SJ; Hampel T
    Nervenarzt; 2007 Sep; 78(9):1052-7. PubMed ID: 17492420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Dementia with Lewy bodies].
    Iseki E
    Ryoikibetsu Shokogun Shirizu; 2003; (40):253-6. PubMed ID: 14626113
    [No Abstract]   [Full Text] [Related]  

  • 27. Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil.
    Skjerve A; Nygaard HA
    Int J Geriatr Psychiatry; 2000 Dec; 15(12):1147-51. PubMed ID: 11180473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Donepezil in the treatment of vascular dementia.
    Ebell MH
    Am Fam Physician; 2004 Nov; 70(9):1681-2. PubMed ID: 15554484
    [No Abstract]   [Full Text] [Related]  

  • 29. Continuing donepezil produces cognitive benefits in Alzheimer's.
    Bland P
    Practitioner; 2012 Apr; 256(1750):5. PubMed ID: 22792683
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effectiveness of donepezil in the treatment of mild or moderate Alzheimer's disease.
    López-Bastida J; Hart W; García-Pérez L; Linertová R
    J Alzheimers Dis; 2009; 16(2):399-407. PubMed ID: 19221429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of behavioural problems in dementia using a cholinesterase inhibitor: the ethical questions.
    Coulson BS; Fenner SG; Almeida OP
    Aust N Z J Psychiatry; 2002 Apr; 36(2):259-62. PubMed ID: 11982550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe worsening of parkinsonism in Lewy body dementia due to donepezil.
    Onofrj M; Thomas A
    Neurology; 2003 Nov; 61(10):1452. PubMed ID: 14638981
    [No Abstract]   [Full Text] [Related]  

  • 33. Significant dose differences in donepezil purchased from the United States and Canada.
    Wang CZ; Du GJ; Zhen Z; Calway T; Yuan CS
    Ann Intern Med; 2011 Aug; 155(4):279-80. PubMed ID: 21844564
    [No Abstract]   [Full Text] [Related]  

  • 34. The value of the managed entry of new drugs: a case study of donepezil.
    Payne K; Davies LM; Noyce PR; Weiss MC
    Int J Technol Assess Health Care; 2003; 19(1):114-28. PubMed ID: 12701944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donepezil for cognitive deficits following traumatic brain injury: a case report.
    Bourgeois JA; Bahadur N; Minjares S
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):463-4. PubMed ID: 12426418
    [No Abstract]   [Full Text] [Related]  

  • 36. Cholinergic symptoms with low serum cholinesterase from therapeutic cholinesterase inhibitor toxicity.
    Leikin JB; Braund V; DesLauris C
    Am J Emerg Med; 2014 Jul; 32(7):815.e3-4. PubMed ID: 24589024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug treatment of REM sleep behavior disorders in dementia with Lewy bodies.
    Massironi G; Galluzzi S; Frisoni GB
    Int Psychogeriatr; 2003 Dec; 15(4):377-83. PubMed ID: 15000417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of low-dose donepezil for visual hallucinations in a patient with dementia with Lewy bodies.
    Fujita Y; Takebayashi M
    Psychiatry Clin Neurosci; 2010 Jun; 64(3):336. PubMed ID: 20602734
    [No Abstract]   [Full Text] [Related]  

  • 39. A case series of D-cycloserine added to donepezil in the treatment of Alzheimer's disease.
    Falk WE; Daly EJ; Tsai GE; Gunther J; Brown P
    J Neuropsychiatry Clin Neurosci; 2002; 14(4):466-7. PubMed ID: 12426422
    [No Abstract]   [Full Text] [Related]  

  • 40. Donepezil use in Down syndrome.
    Kishnani PS; Sullivan JA; Spiridigliozzi GA; Heller JH; Crissman BG
    Arch Neurol; 2004 Apr; 61(4):605-6. PubMed ID: 15096417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.